Company news

Exagen Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Exagen Inc. Reports Strong Third Quarter 2023 Results

November 12, 2023

Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers

November 8, 2023

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

November 1, 2023

Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023

October 29, 2023

Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting

September 27, 2023

Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

September 11, 2023

Exagen Inc. Reports Strong Second Quarter 2023 Results

August 6, 2023

Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference

July 25, 2023

Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023

July 24, 2023

Exagen Inc. Appoints Paul Kim to Board of Directors

July 23, 2023

Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference

May 29, 2023

Exagen Inc. Reports First Quarter 2023 Results

May 14, 2023

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023

April 23, 2023

Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

March 19, 2023

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023

March 5, 2023

Exagen Inc. to Participate in Upcoming March Conferences

February 26, 2023

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 29, 2023

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

January 22, 2023

Exagen Inc. Reports Third Quarter 2022 Results

November 13, 2022

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022

October 30, 2022

Exagen Announces Appointment of John Aballi as CEO

October 16, 2022

Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer

October 3, 2022

Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting

September 19, 2022

Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients

August 31, 2022

Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA

August 3, 2022

Exagen Inc. Reports Second Quarter 2022 Results

August 3, 2022

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

July 24, 2022

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

July 20, 2022

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

July 4, 2022

Exagen Inc. Expands Coverage with MediNcrease

June 8, 2022

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

May 25, 2022

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

May 15, 2022

Exagen Inc. Reports First Quarter 2022 Results

May 10, 2022

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

May 10, 2022

Exagen Announces Five-Week Campaign for Lupus Awareness Month

April 30, 2022

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

April 24, 2022

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

April 19, 2022

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

March 29, 2022

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

March 21, 2022

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

March 21, 2022

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

March 15, 2022

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

March 8, 2022

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

March 7, 2022

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 1, 2022

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

January 8, 2022

Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 16, 2021

Exagen Inc. Reports Third Quarter 2021 Results

November 9, 2021

Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum

November 3, 2021

Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021

October 26, 2021

Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus

October 26, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.